Last week , the fda granted the menopause application conditional approal , saying another clinical trial would be required to assess possible lier and cardioascular side effects 上個星期, fda有條件的批準(zhǔn)了更年期綜合癥上的應(yīng)用,要求進(jìn)行另外的臨床試驗來評估可能引起的肝和心血管的不良反應(yīng)。